No Data
PEIJIA-B: Annual Report 2024
Market Sentiment Around Loss-Making Peijia Medical Limited (HKG:9996)
The industry is hotly discussing the future trends of nuclear medicine, will Hybrid NewCo become a new model for the RDC Industry to venture abroad? | Industry Observation
① Today, the 2025 Future XDC New Drug Conference is held in Chengdu; ② Executives from companies such as Baillie Tianheng and Kelun Botai, along with numerous experts and scholars in the industry, will jointly discuss cutting-edge technologies in ADC/nuclear drug development, overseas strategies, and other Topics.
Express News | Peijia Medical - Registration Application for Taurustriotm Transcatheter Aortic Valve System Accepted by Nmpa
Everbright: Import substitution is expected to accelerate, pay attention to the rising market share of domestic surgical robots.
Everbright stated that the import substitution is expected to accelerate, paying attention to the rise in market share of domestic surgical robots.
PEIJIA-B (09996.HK): The National Medical Products Administration approved the registration application for the YonFlow flow-directed mesh Brackets.
On April 9, Gelonghui reports that PEIJIA-B (09996.HK) announced that the registration application for the YonFlow blood flow-guided mesh brackets has been approved by the National Medical Products Administration. The YonFlow blood flow-guided mesh brackets were developed by Jiangsu Nuanyang Medical Instruments Co., Ltd., and are the world's first completely retrievable blood flow-guided mesh bracket system after full release, allowing users to precisely control the device during surgery. At the same time, the product's cobalt-chromium alloy material provides stronger radial support and good vascular wall conformity.
Peijia Medical Limited's (HKG:9996) 29% Share Price Plunge Could Signal Some Risk
